Skip to main content
Current Drug Metabolism aims to cover all the latest and outstanding developments in drug metabolism and disposition. The journal serves as an international forum for the publication of timely reviews in drug metabolism. Current Drug Metabolism is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments. The journal covers the following areas:

In vitro systems including CYP-450; enzyme induction and inhibition; drug-drug interactions and enzyme kinetics; pharmacokinetics, toxicokinetics, species scaling and extrapolations; P-glycoprotein and transport carriers; target organ toxicity and interindividual variability; drug metabolism and disposition studies; extrahepatic metabolism; phase I and phase II metabolism; recent developments for the identification of drug metabolites and adducts.

Publisher: Bentham Science Publishers

More about this publication?
Volume 9, Number 10, 2008

Articles

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Molecular Mechanisms Underlying St. John's Wort Drug Interactions
pp. 1027-1037(11)
Authors: Kober, Maike; Pohl, Kerstin; Efferth, Thomas

Favourites:
ADD

Transcriptome and Proteome Analyses of Drug Interactions with Natural Products
pp. 1038-1048(11)
Authors: Fang, Hai; Wang, Kankan; Zhang, Ji

Favourites:
ADD

Epidemiology of NHP-Drug Interactions: Identification and Evaluation
pp. 1049-1054(6)
Authors: Brulotte, J.; Vohra, S.

Favourites:
ADD

Clinical Risk Management of Interactions Between Natural Products and Drugs
pp. 1055-1062(8)
Authors: De Smet, Peter A.G.M.; Floor-Schreudering, Annemieke; Bouvy, Marcel L.; Wensing, Michel

Favourites:
ADD

Clinical Evidence of Herb-Drug Interactions: A Systematic Review by the Natural Standard Research Collaboration
pp. 1063-1120(58)
Authors: Ulbricht, C.; Chao, W.; Costa, D.; Rusie-Seamon, E.; Weissner, W.; Woods, J.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content